Amrutanjan Health Care Limited · NSE:AMRUTANJAN
Amrutanjan Health Care — Q3 FY22 Earnings Presentation
18 slides from Amrutanjan Health Care's earnings presentation, Feb 12, 2022
Slide 1: Cover letter to stock exchanges
AHCL/ SE/ 55/2021-22 February 11, 2022 The National Stock Exchange of India Limited BSE Limited “Exchange Plaza”, C-1, Block G Department of Corporate Services Bandra- Kurla Complex, Bandra (E) 1s Floor, : Mumbai 400 051 P.J. Towers, Dalal Street, ISIN: INEO98F01031 Mumbai 400 001 Symbol : AMRUTANJA
Slide 2: Investor Presentation - Quarter & Period Ended 31st December 2021
Amrutanjan Health Care Limited Investor Presentation - Quarter & Period Ended 31st December 2021 Date: 11th February 2022
Slide 3: Contents
Contents a. Business Update b. YTD Dec’21 Performance c. Q3 FY22 Performance d. Way Forward Investor Presentation | Quarter and Period Ended 31st December 2021 2
Slide 4: Business Update
Business Update Investor Presentation | Quarter and Period Ended 31st December 2021 3
Slide 5: Business Update
Business Update • Comfy, Roll-On for Head, Body and Electro Plus continue to be growth drivers. • Covid related growth is not seen anymore. • Super Stockist net work continues to be built to drive rural penetration. • Comfy is the 4th largest Sanitary Napkin brand in India by volume market share (So
Slide 6: New Head Range TVC
Business Update New Head Range TVC Yellow Balm White Balm Head Roll-On Investor Presentation | Quarter and Period Ended 31st December 2021
Slide 7: New Products
Business Update W Amrutanjan Comfy Snug Fit Regular Cottony NE UCT O D PR Investor Presentation | Quarter and Period Ended 31st December 2021 6
Slide 8: YTD Dec'21 Performance
YTD Dec’21 Performance Investor Presentation | Quarter and Period Ended 31st December 2021 7
Slide 9: Financials – YTD Dec'21
Financials – YTD Dec’21 (Rs. in Crores) Gross Sales Profit Before Tax Profit After Tax 331.48 52.48 263.04 70.56 68.19 50.96 YTD Dec'21 YTD Dec'20 YTD Dec'21 YTD Dec'20 YTD Dec'21 YTD Dec'20 Growth: 26.02% Growth: 3.48% Growth: 2.98% Investor Presentation | Quarter and Period Ended 31st December 202
Slide 10: Financials – YTD Dec'21
Financials – YTD Dec’21 (Rs. in Crores) Employee Benefit Expenses 40.00 35.93 35.00 29.51 30.00 25.00 20.00 15.00 10.00 5.00 - YTD Dec'21 YTD Dec'20 Increase: 21.76% Advertisement & Selling Expenses Other Expenses 50.00 46.47 24.00 23.36 45.00 23.00 40.00 35.00 22.00 30.00 27.39 25.00 21.00 20.00 19
Slide 11: Financials – YTD Dec'21 – OTC Division
Financials – YTD Dec’21 – OTC Division (Rs. in Crores) Gross Sales - OTC 307.79 Notes: 252.44 • Key raw material - Menthol Crystal price is lower when compared to YTD Dec’20. YTD Dec'21 YTD Dec'20 • The prices of packing materials are Growth: 21.93% higher when compared to YTD Dec’20. Gross Sales -
Slide 12: Financials – YTD Dec'21 – Beverage Division
Financials – YTD Dec’21 – Beverage Division (Rs. in Crores) Gross Sales - Beverages 22.51 Notes: 9.64 • Gross Margin has improved by 1,985 basis points when compared to YTD YTD Dec'21 YTD Dec'20 Dec’20 mainly due to product mix. Growth: 133.51% • Advertisement spend is at 2.94 cr Gross Sales - Elect
Slide 13: Q3 FY22 Performance
Q3 FY22 Performance Investor Presentation | Quarter and Period Ended 31st December 2021 12
Slide 14: Financials – Q3 FY22
Financials – Q3 FY22 (Rs. in Crores) Gross Sales Profit Before Tax Profit After Tax 122.99 20.99 28.14 20.58 110.77 27.92 Q3 FY22 Q3 FY21 Q3 FY22 Q3 FY21 Q3 FY22 Q3 FY21 Growth: 11.03% Investor Presentation | Quarter and Period Ended 31st December 2021 13
Slide 15: Financials – Q3 FY22
Financials – Q3 FY22 (Rs. in Crores) Gross Sales - OTC Gross Sales - Beverages 118.18 4.35 2.59 107.62 Q3 FY22 Q3 FY21 Q3 FY22 Q3 FY21 Growth: 9.81% Growth: 67.95% Gross Sales - Comfy Gross Sales - Electro Plus 18.15 3.71 2.06 16.32 Q3 FY22 Q3 FY21 Q3 FY22 Q3 FY21 Growth: 11.21% Growth: 80.10% Inves
Slide 16: Way Forward
Way Forward Investor Presentation | Quarter and Period Ended 31st December 2021 15
Slide 17: Way Forward
Way Forward We remain focused on executing our key priorities: • Expand distribution • Go digital • Grow E-Commerce vertical • Costs control Investor Presentation | Quarter and Period Ended 31st December 2021 16
Slide 18: Investor Presentation | Quarter and Period Ended 31st December 2021
Investor Presentation | Quarter and Period Ended 31st December 2021 17
Amrutanjan Health Care — Q3 FY22 Earnings Presentation on 6ix